Interventional Cardiology Unit, GVM Care & Research Maria Cecilia Hospital, Cotignola, Italy
Carotid artery stenting (CAS) is undergoing a new “Renaissance”. Increased operator experience together with advances in technology have provided enough answers to the known controversies traditionally associated with CAS, with a definite improvement in clinical outcomes observed in the latest trials1. The reasons for this deserve an adequate critical appraisal.
It is a fact that carotid angioplasties are emboli-generating procedures. Cerebral embolisation is the main explanation for the post-procedural cerebral events observed after CAS2, with large-burden, friable, thrombotic and ulcerated plaques being associated with a higher risk of embolisation3,4. The use of neuroprotection devices has significantly reduced the ...
Sign in to read and download the full articleForgot your password?
No account yet? Sign up for free!Create my pcr account
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com
Read next articleTranscatheter tricuspid intervention: the new challenge of structural valve intervention